KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Current Taxes: 2016-2019

Historic Current Taxes for Supernus Pharmaceuticals (SUPN) over the last 4 years, with Dec 2019 value amounting to $2.4 million.

  • Supernus Pharmaceuticals' Current Taxes rose 836.87% to $25.1 million in Q2 2020 from the same period last year, while for Jun 2020 it was $25.1 million, marking a year-over-year increase of 836.87%. This contributed to the annual value of $2.4 million for FY2019, which is 80.26% down from last year.
  • As of FY2019, Supernus Pharmaceuticals' Current Taxes stood at $2.4 million, which was down 80.26% from $12.4 million recorded in FY2018.
  • Supernus Pharmaceuticals' Current Taxes' 5-year high stood at $15.9 million during FY2017, with a 5-year trough of $7,000 in FY2016.
  • Its 3-year average for Current Taxes is $10.3 million, with a median of $12.4 million in 2018.
  • In the last 5 years, Supernus Pharmaceuticals' Current Taxes surged by 227,585.71% in 2017 and then crashed by 80.26% in 2019.
  • Over the past 4 years, Supernus Pharmaceuticals' Current Taxes (Yearly) stood at $7,000 in 2016, then surged by 227,585.71% to $15.9 million in 2017, then decreased by 22.34% to $12.4 million in 2018, then slumped by 80.26% to $2.4 million in 2019.